Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9265759 Compositions and methods of treating retinal disease

Patent 9265759 was granted and assigned to Aldeyra Therapeutics on February, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12128013 Toxic aldehyde related diseases and treatment

0

Edits on 21 Aug, 2024

"update inverses"

edited on 21 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12064516 Pharmaceutical formulations and uses thereof

0

Edits on 13 Jun, 2024

"update inverses"

edited on 13 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12006298 Polymorphic compounds and uses thereof

0

Edits on 4 Dec, 2023

"Add patent abstract"

edited on 4 Dec, 2023

Edits made to:

Article (+270 characters)

Article

Patent abstract

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.

Edits on 18 Oct, 2023

"update inverses"

edited on 18 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11786518 Ophthalmic formulations and uses thereof

Edits on 4 Oct, 2023

"update inverses"

edited on 4 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11771664 Toxic aldehyde related diseases and treatment

Edits on 29 Sep, 2023

"Add patent inventor(s)"

edited on 29 Sep, 2023

Edits made to:

Infobox (+3 properties)

Infobox

Patent Inventor Names

John Clifford Chabala0

John E. Dowling0

Thomas A. Jordan0

Edits on 19 Jul, 2023

"update inverses"

edited on 19 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11701331 Toxic aldehyde related diseases and treatment

0

Edits on 14 Jul, 2023

"Remove leading 0 from patent number"

edited on 14 Jul, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09265759 Compositions and methods of treating retinal disease US Patent 9265759 Compositions and methods of treating retinal disease

Infobox

Patent Number

09265759

Patent Number

9265759

Edits on 26 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 26 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=09265759

Edits on 17 Jun, 2022

"Entity importer update"

edited on 17 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09265759

Edits on 5 Jan, 2022

"Created via: Entity Importer"

created this topic on 5 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 09265759 Compositions and methods of treating retinal disease

Infobox

Is a

Patent applicant

Aldeyra Therapeutics

Current assignee

Aldeyra Therapeutics

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09265759

Date of patent

February 23, 2016

Patent application number

14581462

Date Filed

December 23, 2014

Patent primary examiner

Wu-Cheng Winston Shen

Find more entities like US Patent 9265759 Compositions and methods of treating retinal disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool